These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19036180)

  • 21. Tadalafil: new preparation. Slightly more convenient, but poorly assessed in organic disorders.
    Prescrire Int; 2003 Dec; 12(68):213-5. PubMed ID: 14986690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of tadalafil on erectile dysfunction: on-demand versus once-daily dosing].
    Tang YX; Zhou HB; Peng SL; Jiang XZ; He LY; Li DJ
    Zhonghua Nan Ke Xue; 2012 May; 18(5):472-4. PubMed ID: 22741449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in side-effect duration and related bother levels between phosphodiesterase type 5 inhibitors.
    Taylor J; Baldo OB; Storey A; Cartledge J; Eardley I
    BJU Int; 2009 May; 103(10):1392-5. PubMed ID: 19154494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary embolism after tadalafil ingestion.
    Chen HC; Wang CS; Chuang SH; Wang CY
    Pharm World Sci; 2008 Oct; 30(5):610-2. PubMed ID: 18548330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tadalafil for erectile dysfunction: an overview].
    Duan XG
    Zhonghua Nan Ke Xue; 2013 Apr; 19(4):380-3. PubMed ID: 23678721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury.
    Giuliano F; Sanchez-Ramos A; Löchner-Ernst D; Del Popolo G; Cruz N; Leriche A; Lombardi G; Reichert S; Dahl P; Elion-Mboussa A; Casariego J
    Arch Neurol; 2007 Nov; 64(11):1584-92. PubMed ID: 17846260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tadalafil for erectile dysfunction: efficacy evaluation].
    Wang X
    Zhonghua Nan Ke Xue; 2009 Apr; 15(4):379-83. PubMed ID: 19472916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tadalafil: a phosphodiesterase-5 inhibitor for benign prostatic hyperplasia.
    Cantrell MA; Baye J; Vouri SM
    Pharmacotherapy; 2013 Jun; 33(6):639-49. PubMed ID: 23529917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the acute effects of tadalafil on the cardiovascular system based on examination of serum oxidative status and paraoxonase activity in men with erectile dysfunction: a preliminary study.
    Verit A; Savas M; Ciftci H; Aksoy N; Taskin A; Topal U
    Int J Impot Res; 2010; 22(2):115-9. PubMed ID: 20010611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cardiological aspects of tadalafil safety].
    Talibov OB
    Urologiia; 2009; (3):82, 84-6. PubMed ID: 19670822
    [No Abstract]   [Full Text] [Related]  

  • 31. Cialis (tadalafil): a new treatment for erectile dysfunction.
    Minhas S; Kalsi JS; Ralph DJ
    Hosp Med; 2003 Oct; 64(10):589-92. PubMed ID: 14584238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of on demand tadalafil in the treatment of East and Southeast Asian men with erectile dysfunction: a randomized double-blind, parallel, placebo-controlled clinical study.
    Yip WC; Chiang HS; Mendoza JB; Tan HM; Li MK; Wang WC; Kopernicky V
    Asian J Androl; 2006 Nov; 8(6):685-92. PubMed ID: 16855765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of tadalafil for the treatment of erectile dysfunction].
    Liu ZY; Sun YH
    Zhonghua Nan Ke Xue; 2008 Apr; 14(4):377-80. PubMed ID: 18481436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies.
    Porst H; Gacci M; Büttner H; Henneges C; Boess F
    Eur Urol; 2014 Feb; 65(2):455-64. PubMed ID: 24119319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of tadalafil in improving sexual satisfaction and overall satisfaction in men with mild, moderate, and severe erectile dysfunction: a retrospective pooled analysis of data from randomized, placebo-controlled clinical trials.
    Rosen RC; Shabsigh R; Kuritzky L; Wang WC; Sides GD
    Curr Med Res Opin; 2005 Nov; 21(11):1701-9. PubMed ID: 16307689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of 12-month tadalafil therapy for erectile dysfunction on couple relationships: results from the DETECT study.
    Verheyden B; Roumeguère T; Bitton A; Belger M; Schmitt H;
    J Sex Med; 2009 Dec; 6(12):3458-68. PubMed ID: 19832933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular safety update of Tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of Tadalafil with as needed, three times-per-week or once-a-day dosing.
    Kloner RA; Jackson G; Hutter AM; Mittleman MA; Chan M; Warner MR; Costigan TM; Vail GM
    Am J Cardiol; 2006 Jun; 97(12):1778-84. PubMed ID: 16765134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cardiovascular-protective effect of tadalafil in the treatment of erectile dysfunction].
    Liu Y
    Zhonghua Nan Ke Xue; 2013 Dec; 19(12):1147-51. PubMed ID: 24432631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review of tadalafil in the treatment of erectile dysfunction.
    Meuleman EJ
    Expert Opin Pharmacother; 2003 Nov; 4(11):2049-56. PubMed ID: 14596658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An observational cohort study investigating the cardiovascular safety of tadalafil when prescribed in primary care in England: mortality due to ischaemic heart disease.
    Hazell L; Boshier A; Harris S; Wilton LV; Shakir SA
    BJU Int; 2007 Feb; 99(2):387-93. PubMed ID: 17313426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.